Session 3: Boosting primary and recurrent rectal cancer: how far can we push the radiotherapy envelope?
Colorectal Dis
; 20 Suppl 1: 88-91, 2018 05.
Article
en En
| MEDLINE
| ID: mdl-29878674
ABSTRACT
Neoadjuvant pelvic radiotherapy is widely used for patients with advanced rectal cancer. The trade-off between dose and response is well-established, yet little consensus remains on the precise methods of delivery and doses given in different scenarios. Professor Vuong reviews the evidence base and trial evidence on the escalation of radiotherapy dose and the methods of achieving this.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias del Recto
/
Radiocirugia
/
Terapia Neoadyuvante
/
Radioterapia de Intensidad Modulada
/
Recurrencia Local de Neoplasia
Tipo de estudio:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Colorectal Dis
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2018
Tipo del documento:
Article
País de afiliación:
Reino Unido